Table TDI-3. New clients entering treatment by primary drug, 1997 to 2007 [see all tables in this series...]

Part (iii) New stimulants (amphetamines and MDMA) clients by country and year of treatment (%)

Country		1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007
Belgium	(1)	:	3.4	:	:	:	:	:	:	6.8	:	:
Bulgaria		0.0	0.0	0.0	0.0	0.0	0.2	0.9	1.5	2.0	2.7	2.0
Czech Republic		48.8	56.8	52.8	46.0	47.8	55.0	55.6	59.0	60.1	61.7	63.8
Denmark		:	:	11.0	7.0	:	10.3	12.7	14.2	11.2	16.8	15.5
Germany		:	:	:	10.2	11.4	10.0	10.2	9.4	9.4	10.0	10.4
Estonia		:	:	:	:	:	:	:	:	:	:	:
Ireland		7.0	4.8	5.7	6.5	9.9	8.6	8.0	6.7	5.7	3.8	4.5
Greece		0.3	0.0	0.2	0.3	0.4	0.7	0.6	0.7	0.1	0.4	0.1
Spain		1.1	2.3	2.1	2.7	3.0	3.7		1.7	1.9	2.0
France		1.8	:	1.6	:	:	:	2.1	:	1.2	0.9	0.8
Italy		0.6	0.9	1.1	1.0	1.0	1.0	1.0	1.0	0.9	0.6	0.5
Cyprus						6.1	6.0	6.2	5.3	1.4	3.1	1.3
Latvia			7.0	6.7	3.9	5.4	13.3	15.6	26.8	23.8	26.4	23.5
Lithuania							3.0	4.8	2.4	0.0	4.3	6.6
Luxembourg	(2)	2.0	3.0	2.0	1.0	1.0	0.0	0.0	2.5	0.4	2.4	2.9
Hungary	(3)	12.2	14.0	10.7	7.5	7.0	6.3	8.2	7.9	11.0	9.6	12.2
Malta	(4)	0.4	:	:	:	:	:	1.2	0.0	1.6	5.0	:
Netherlands		9.5	8.1	6.7	4.8	4.1	5.6	7.0	8.3	9.1	9.5	10.3
Austria	(5)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	4.1
Poland	(6)	3.8	6.0	6.7	5.8	6.0	8.1	11.9	:	:	:	:
Portugal		:	:	0.0	0.0	:	:	0.8	0.5	0.2	0.4	0.4
Romania						0.3	0.5	1.0	1.0	1.8	0.8	1.4
Slovenia	(7)	0.2	:	0.7	:	:	1.0	1.0	1.1	1.2	0.7	0.4
Slovakia		2.6	3.2	2.3	6.8	7.8	15.1	25.4	32.1	30.4	32.6	33.9
Finland			41.1	41.9	30.8	30.0	33.9	33.9	30.9	26.3	24	24.1
Sweden	(8)				28.7	32.3	34.2	32.1	28.6	25.6	27.1	28.6
United Kingdom	(9)	9.0	9.0	8.0	4.0	3.0	3.0	6.0	7.0	5.6	5.0	5.9
Croatia		:	:	:	:	:	:	:	:	:	11.2	10.3
Turkey		:	:	:	:	:	:	:	7.5	7.3	4.2	4.6
Norway		:	:	:	:	:	:	:	:	:	:	:

Notes:

 : indicates data not available 

 (1) 1997 and 2000 data were available but they were not included due to a lack of comparability. 1998 data refers to opioids in general. 2005 data only refers to outpatient and low-threshold agencies and do not cover Brussels Capital Region. 

 (2) Data refer to all treatments.                         

 (3) Data refer to all treatments. For 2004 data refer to first treatments. The source of the data has changed in 2007 : from “Hungarian National Focal Point – National statistical programme” (1997-2006) to “Hungarian National Focal Point – TDI data collection” (2007). The change limits the comparability of the 2007 data to previous data. 

 (4) In order to include time trends, data reported in Table 3 refer to one outpatient centre for which data were available for the whole time period. 

 (5) In the case of Austria, up to 2005 data only refer to clients in substitution treatment, using opioids as primary drug. Since 2006, data are based on new DOKLI data collection system. 

 (6) Data refer to all treatments up to 2002. For 2003 data refer to first treatments. For 2004–07, data were not available and therefore not included in the analysis. 

 (7) Data for 2004 includes data for outpatient clients and clients treated in prison. Data for outpatient clients was validated, however data collection for prison clients was still in the process of development, thus figures are underestimated 

 (8) Data before 2000 were available but were not included because of a major change in the reporting systrem, which would have biased the comparison of data over time. The system is under development and every year new units are added to the information system. 2007 data do not cover treatment units in prisons. 

 (9) Data refer to all treatments up to 2002 and to new treatments from 2003. Before 2003, data only refer to amphetamines. 

 See also ‘General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2008 — Standard table 3 and TDI   

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)